BOOK
Study Guide for Pharmacology for Canadian Health Care Practice - E-Book
Linda Lane Lilley | Shelly Rainforth Collins | Julie S. Snyder | Gorospe Franklin F.
(2016)
Additional Information
Book Details
Abstract
Master content from the textbook with this helpful study tool! Designed to accompany Lilley's Pharmacology for Canadian Health Care Practice, 2nd edition, this study guide helps you to understand and apply material from each chapter in the text. Worksheets for each chapter include multiple-choice questions, critical thinking and application questions, case studies, and other activities.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Table of contents | IFC | ||
| Front matter | iii | ||
| Study guide for pharmacology for Canadian health care practice third Canadian edition | iii | ||
| Copyright page | iv | ||
| Student study tips | 1 | ||
| Time management | 1 | ||
| General guidelines | 1 | ||
| Establish goals and create action plans | 1 | ||
| Guidelines for setting goals | 1 | ||
| Guidelines for action statements | 2 | ||
| Organize tasks and create schedules | 2 | ||
| Guidelines for organizing tasks | 2 | ||
| Guidelines for creating workable schedules | 2 | ||
| Choose to use your resources | 5 | ||
| Your textbook | 5 | ||
| Your professor or instructor | 5 | ||
| Your colleagues | 6 | ||
| Choose to develop your vocabulary | 6 | ||
| Use dictionaries | 6 | ||
| Reference the text glossary | 6 | ||
| Create flash cards | 7 | ||
| Use what you know | 7 | ||
| Learn the standard abbreviations | 7 | ||
| Establish relationships | 7 | ||
| Choose to take effective lecture notes | 8 | ||
| Why take notes? | 8 | ||
| Note-taking problems | 8 | ||
| Note-taking solutions | 8 | ||
| Stage 1: Be prepared | 8 | ||
| Stage 2: Active listening | 8 | ||
| Stage 3: In-class note taking | 8 | ||
| Stage 4: Out-of-class reworking | 9 | ||
| Stage 5: Frequent, active review | 10 | ||
| When to review. | 10 | ||
| How to review. | 10 | ||
| Two-page split-note variation. | 11 | ||
| Choose to master your textbooks | 11 | ||
| General guidelines | 11 | ||
| Text notation systems | 12 | ||
| Text conventions | 12 | ||
| Language conventions | 12 | ||
| How to highlight and underline | 12 | ||
| Review | 12 | ||
| When | 12 | ||
| How | 13 | ||
| How often | 13 | ||
| Choose to be successful in exams | 13 | ||
| Rules for success on exams | 13 | ||
| Strategies for reviewing class notes | 14 | ||
| Strategies for reviewing the textbook | 14 | ||
| Strategies for reviewing terminology | 14 | ||
| On-the-run action | 15 | ||
| Exam time | 15 | ||
| Tips for answering the questions | 15 | ||
| Strategies for specific types of questions | 16 | ||
| Strategy for multiple-choice questions | 16 | ||
| Recall. | 17 | ||
| Look-alike answers. | 17 | ||
| Absolutes. | 17 | ||
| Negatives and exceptions. | 17 | ||
| Strategy for short-answer and essay questions | 18 | ||
| Two key issues | 18 | ||
| Five steps to good essay answers | 18 | ||
| Strategy for true-or-false questions | 19 | ||
| Read the question. | 19 | ||
| Assume that the statement is true. | 20 | ||
| Strategies for analysis. | 20 | ||
| Absolutes and qualifiers. | 20 | ||
| Stated in the negative. | 20 | ||
| Strings. | 20 | ||
| Conclusion | 21 | ||
| 1 Nursing practice in canada and drug therapy | 23 | ||
| Critical thinking and application | 24 | ||
| Case study | 24 | ||
| 2 Pharmacological principles | 26 | ||
| Critical thinking and application | 28 | ||
| Case study | 28 | ||
| 3 Legal and ethical considerations | 29 | ||
| Chapter review and examination preparation | 29 | ||
| Critical thinking and application | 30 | ||
| Case study | 31 | ||
| 4 Patient focused considerations | 32 | ||
| Chapter review and examination preparation | 32 | ||
| Critical thinking and application | 33 | ||
| Case study | 33 | ||
| 5 Gene therapy and pharmacogenomics | 34 | ||
| Chapter review and examination preparation | 34 | ||
| Case study | 34 | ||
| 6 Medication errors: Preventing and responding | 36 | ||
| Chapter review and examination preparation | 36 | ||
| Case study | 37 | ||
| 7 Patient education and drug therapy | 38 | ||
| Chapter review and examination preparation | 38 | ||
| Critical thinking and application | 39 | ||
| Case study | 39 | ||
| 8 Over-the-counter drugs and natural health products | 41 | ||
| Double puzzle | 41 | ||
| Chapter review and examination preparation | 41 | ||
| Case study | 42 | ||
| 9 Vitamins and minerals | 44 | ||
| Chapter review and examination preparation | 44 | ||
| Critical thinking and application | 45 | ||
| Case study | 46 | ||
| 10 Principles of drug administration | 47 | ||
| Chapter review and examination preparation | 47 | ||
| Critical thinking and application | 48 | ||
| Case study | 49 | ||
| 11 Analgesic drugs | 50 | ||
| Chapter review and examination preparation | 50 | ||
| Critical thinking crossword | 52 | ||
| Case study | 53 | ||
| 12 General and local anaesthetics | 54 | ||
| Chapter review and examination preparation | 54 | ||
| Critical thinking and application | 55 | ||
| Critical thinking crossword | 55 | ||
| Case study | 56 | ||
| 13 Central nervous system depressants and muscle relaxants | 57 | ||
| Chapter review and examination preparation | 57 | ||
| Critical thinking and application | 58 | ||
| Case study | 59 | ||
| 14 Central nervous system stimulants and related drugs | 60 | ||
| Chapter review and examination preparation | 60 | ||
| Critical thinking and application | 61 | ||
| Case study | 61 | ||
| 15 Antiepileptic drugs | 62 | ||
| Chapter review and examination preparation | 62 | ||
| Critical thinking and application | 63 | ||
| Critical thinking crossword | 64 | ||
| Case study | 64 | ||
| 16 Antiparkinsonian drugs | 65 | ||
| Chapter review and examination preparation | 65 | ||
| Critical thinking and application | 66 | ||
| Case study | 66 | ||
| 17 Psychotherapeutic drugs | 67 | ||
| Chapter review and examination preparation | 67 | ||
| Critical thinking and application | 69 | ||
| Case study | 69 | ||
| 18 Substance misuse | 70 | ||
| Chapter review and examination preparation | 70 | ||
| Critical thinking and application | 71 | ||
| Case study | 71 | ||
| 19 Adrenergic drugs | 72 | ||
| Chapter review and examination preparation | 72 | ||
| Critical thinking and application | 73 | ||
| Case study | 73 | ||
| 20 Adrenergic-blocking drugs | 74 | ||
| Chapter review and examination preparation | 74 | ||
| Critical thinking and application | 75 | ||
| Case study | 75 | ||
| 21 Cholinergic drugs | 76 | ||
| Chapter review and examination preparation | 76 | ||
| Critical thinking and application | 77 | ||
| Case study | 78 | ||
| 22 Cholinergic-blocking drugs | 79 | ||
| Chapter review and examination preparation | 79 | ||
| Critical thinking and application | 80 | ||
| Case study | 80 | ||
| 23 Antihypertensive drugs | 81 | ||
| Chapter review and examination preparation | 81 | ||
| Critical thinking and application | 82 | ||
| Critical thinking crossword | 83 | ||
| Case study | 84 | ||
| 24 Antianginal drugs | 85 | ||
| Chapter review and examination preparation | 85 | ||
| Critical thinking and application | 86 | ||
| Case study | 86 | ||
| 25 Heart failure drugs | 87 | ||
| Chapter review and examination preparation | 87 | ||
| Critical thinking and application | 88 | ||
| Case study | 88 | ||
| 26 Antidysrhythmic drugs | 89 | ||
| Chapter review and examination preparation | 89 | ||
| Critical thinking and application | 90 | ||
| Case study | 90 | ||
| 27 Coagulation-modifier drugs | 91 | ||
| Chapter review and examination preparation | 91 | ||
| Critical thinking and application | 93 | ||
| Case study | 94 | ||
| 28 Antilipemic drugs | 95 | ||
| Chapter review and examination preparation | 95 | ||
| Critical thinking and application | 95 | ||
| Case study | 96 | ||
| 29 Diuretic drugs | 97 | ||
| Chapter review and examination preparation | 97 | ||
| Critical thinking and application | 98 | ||
| Case study | 99 | ||
| 30 Fluids and electrolytes | 100 | ||
| Chapter review and examination preparation | 100 | ||
| Critical thinking and application | 101 | ||
| Case study | 101 | ||
| 31 Pituitary drugs | 102 | ||
| Chapter review and examination preparation: | 102 | ||
| Critical thinking and application | 103 | ||
| Case study | 103 | ||
| 32 Thyroid and antithyroid drugs | 104 | ||
| Chapter review and examination preparation | 104 | ||
| Critical thinking crossword | 105 | ||
| Case study | 106 | ||
| 33 Antidiabetic drugs | 107 | ||
| Chapter review and examination preparation | 107 | ||
| Critical thinking and application | 108 | ||
| Case study | 109 | ||
| 34 Adrenal drugs | 110 | ||
| Chapter review and examination preparation | 110 | ||
| Critical thinking and application | 111 | ||
| Case study | 111 | ||
| 35 Womens health drugs | 112 | ||
| Chapter review and examination preparation | 112 | ||
| Critical thinking and application | 113 | ||
| Case study | 114 | ||
| 36 Mens health drugs | 115 | ||
| Chapter review and examination preparation | 115 | ||
| Critical thinking and application | 116 | ||
| Case study | 116 | ||
| 37 Antihistamines, decongestants, antitussives, and expectorants | 117 | ||
| Chapter review and examination preparation | 117 | ||
| Critical thinking and application | 118 | ||
| Case study | 119 | ||
| 38 Respiratory drugs | 120 | ||
| Chapter review and examination preparation | 120 | ||
| Critical thinking and application | 121 | ||
| Case study | 122 | ||
| 39 Acid-controlling drugs | 123 | ||
| Chapter review and examination preparation | 123 | ||
| Critical thinking and application | 124 | ||
| Case study | 125 | ||
| 40 Antidiarrheal drugs and laxatives | 126 | ||
| Chapter review and examination preparation | 126 | ||
| Critical thinking and application | 127 | ||
| Critical thinking crossword | 128 | ||
| Case study | 129 | ||
| 41 Antiemetic and antinausea drugs | 130 | ||
| Chapter review and examination preparation | 130 | ||
| Critical thinking and application | 131 | ||
| Case study | 131 | ||
| 42 Nutritional supplements | 132 | ||
| Chapter review and examination preparation | 132 | ||
| Critical thinking and application | 133 | ||
| Critical thinking crossword | 133 | ||
| Case study | 135 | ||
| 43 Antibiotics part 1: Sulphonamides, penicillins, cephalosporins, macrolides, and tetracyclines | 136 | ||
| Chapter review and examination preparation | 136 | ||
| Critical thinking and application | 137 | ||
| Critical thinking crossword | 138 | ||
| Case study | 139 | ||
| 44 Antibiotics part 2: Aminoglycosides, fluoroquinolones, and other drugs | 140 | ||
| Chapter review and examination preparation | 140 | ||
| Critical thinking and application | 141 | ||
| Case study | 141 | ||
| 45 Antiviral drugs | 142 | ||
| Chapter review and examination preparation | 142 | ||
| Critical thinking and application | 143 | ||
| Case study | 143 | ||
| 46 Antitubercular drugs | 144 | ||
| Chapter review and examination preparation | 144 | ||
| Critical thinking and application | 145 | ||
| Case study | 145 | ||
| 47 Antifungal drugs | 146 | ||
| Chapter review and examination preparation | 146 | ||
| Critical thinking and application | 147 | ||
| Case study | 148 | ||
| 48 Antimalarial, antiprotozoal, and anthelmintic drugs | 149 | ||
| Chapter review and examination preparation | 149 | ||
| Critical thinking and application | 150 | ||
| Case study | 150 | ||
| 49 Anti-inflammatory and antigout drugs | 151 | ||
| Chapter review and examination preparation | 151 | ||
| Critical thinking and application | 152 | ||
| Case study | 152 | ||
| 50 Immunosuppressant drugs | 153 | ||
| Chapter review and examination preparation | 153 | ||
| Critical thinking and application | 154 | ||
| Case study | 154 | ||
| 51 Immunizing drugs and pandemic preparedness | 155 | ||
| Chapter review and examination preparation | 155 | ||
| Critical thinking and application | 156 | ||
| Case study | 156 | ||
| 52 Antineoplastic drugs part 1: Cancer overview and cell cyclespecific drugs | 157 | ||
| Chapter review and examination preparation | 157 | ||
| Critical thinking crossword | 159 | ||
| Case study | 160 | ||
| 53 Antineoplastic drugs part 2: Cell cyclenonspecific and miscellaneous drugs | 161 | ||
| Chapter review and examination preparation | 161 | ||
| Critical thinking and application | 162 | ||
| Case study | 162 | ||
| 54 Biological responsemodifying drugs and antirheumatic drugs | 163 | ||
| Chapter review and examination preparation | 163 | ||
| Critical thinking and application | 163 | ||
| Case study | 164 | ||
| 55 Anemia drugs | 165 | ||
| Chapter review and examination preparation | 165 | ||
| Critical thinking and application | 166 | ||
| Case study | 166 | ||
| 56 Dermatological drugs | 167 | ||
| Chapter review and examination preparation | 167 | ||
| Critical thinking and application | 168 | ||
| Case study | 168 | ||
| 57 Ophthalmic drugs | 169 | ||
| Chapter review and examination preparation | 169 | ||
| Critical thinking and application | 170 | ||
| Case study | 171 | ||
| 58 Otic drugs | 172 | ||
| Chapter review and examination preparation | 172 | ||
| Critical thinking and application | 172 | ||
| Case study | 173 | ||
| Overview of dosage calculations | 174 | ||
| Rules to remember | 174 | ||
| Rounding | 174 | ||
| Leading zeros | 175 | ||
| Trailing zeroes | 175 | ||
| Labelling | 175 | ||
| Common sense | 175 | ||
| Interpreting medication labels | 176 | ||
| Section I: Basic conversions using ratio and proportion | 177 | ||
| Basic equivalents | 178 | ||
| Practice problems | 180 | ||
| Section II: Calculating oral doses | 180 | ||
| Practice problems | 182 | ||
| Section III: Reconstituting medications | 182 | ||
| Practice problems | 185 | ||
| Section IV: Child calculations | 186 | ||
| Body surface area–based calculations | 186 | ||
| Weight-based calculations | 187 | ||
| Practice problems | 189 | ||
| Section V: Basic intravenous calculations | 190 | ||
| Practice problems | 192 | ||
| Calculate the following, and prove your answers. | 192 | ||
| Reference | 193 | ||
| Practice quiz | 193 | ||
| Convert the following. | 193 | ||
| Calculate the following, and prove your answers. | 193 | ||
| Answers | 195 | ||
| Worksheets | 195 | ||
| Chapter 1 | 195 | ||
| Nursing practice in canada and drug therapy | 195 | ||
| Chapter 2 | 196 | ||
| Pharmacological principles | 196 | ||
| Chapter 3 | 197 | ||
| Legal and ethical considerations | 197 | ||
| Chapter 4 | 197 | ||
| Patient-focused considerations | 197 | ||
| Chapter 5 | 198 | ||
| Gene therapy and pharmacogenomics | 198 | ||
| Chapter 6 | 198 | ||
| Medication errors: Preventing and responding | 198 | ||
| Chapter 7 | 199 | ||
| Patient education and drug therapy | 199 | ||
| Chapter 8 | 200 | ||
| Over-the-counter drugs and natural health products | 200 | ||
| Chapter 9 | 201 | ||
| Vitamins and minerals | 201 | ||
| Chapter 10 | 201 | ||
| Principles of drug administration | 201 | ||
| Chapter 11 | 203 | ||
| Analgesic drugs | 203 | ||
| Chapter 12 | 203 | ||
| General and local anaesthetics | 203 | ||
| Chapter 13 | 204 | ||
| Central nervous system depressants and muscle relaxants | 204 | ||
| Chapter 14 | 205 | ||
| Central nervous system stimulants and related drugs | 205 | ||
| Chapter 15 | 206 | ||
| Antiepileptic drugs | 206 | ||
| Chapter 16 | 207 | ||
| Antiparkinsonian drugs | 207 | ||
| Chapter 17 | 208 | ||
| Psychotherapeutic drugs | 208 | ||
| Chapter 18 | 208 | ||
| Substance misuse | 208 | ||
| Chapter 19 | 209 | ||
| Adrenergic drugs | 209 | ||
| Chapter 20 | 210 | ||
| Adrenergic-blocking drugs | 210 | ||
| Chapter 21 | 211 | ||
| Cholinergic drugs | 211 | ||
| Chapter 22 | 212 | ||
| Cholinergic-blocking drugs | 212 | ||
| Chapter 23 | 213 | ||
| Antihypertensive drugs | 213 | ||
| Chapter 24 | 213 | ||
| Antianginal drugs | 213 | ||
| Chapter 25 | 214 | ||
| Heart failure drugs | 214 | ||
| Chapter 26 | 215 | ||
| Antidysrhythmic drugs | 215 | ||
| Chapter 27 | 215 | ||
| Coagulation modifier drugs | 215 | ||
| Chapter 28 | 216 | ||
| Antilipemic drugs | 216 | ||
| Chapter 29 | 217 | ||
| Diuretic drugs | 217 | ||
| Chapter 30 | 218 | ||
| Fluids and electrolytes | 218 | ||
| Chapter 31 | 219 | ||
| Pituitary drugs | 219 | ||
| Chapter 32 | 219 | ||
| Thyroid and antithyroid drugs | 219 | ||
| Chapter 33 | 220 | ||
| Antidiabetic drugs | 220 | ||
| Chapter 34 | 221 | ||
| Adrenal drugs | 221 | ||
| Chapter 35 | 222 | ||
| Women’s health drugs | 222 | ||
| Chapter 36 | 223 | ||
| Men’s health drugs | 223 | ||
| Chapter 37 | 224 | ||
| Antihistamines, decongestants, antitussives, and expectorants | 224 | ||
| Chapter 38 | 224 | ||
| Respiratory drugs | 224 | ||
| Chapter 39 | 225 | ||
| Acid-controlling drugs | 225 | ||
| Chapter 40 | 226 | ||
| Antidiarrheal drugs and laxatives | 226 | ||
| Chapter 41 | 227 | ||
| Antiemetic and antinausea drugs | 227 | ||
| Chapter 42 | 227 | ||
| Nutritional supplements | 227 | ||
| Critical thinking crossword | 227 | ||
| Chapter 43 | 228 | ||
| Antibiotics part 1: Sulphonamides, penicillins, cephalosporins, macrolides, and tetracyclines | 228 | ||
| Critical thinking crossword | 228 | ||
| Chapter 44 | 228 | ||
| Antibiotics part 2: Aminoglycosides, fluoroquinolones, and other drugs | 228 | ||
| Chapter 45 | 229 | ||
| Antiviral drugs | 229 | ||
| Chapter 46 | 230 | ||
| Antitubercular drugs | 230 | ||
| Chapter 47 | 231 | ||
| Antifungal drugs | 231 | ||
| Chapter 48 | 231 | ||
| Antimalarial, antiprotozoal, and anthelmintic drugs | 231 | ||
| Chapter 49 | 232 | ||
| Anti-inflammatory and antigout drugs | 232 | ||
| Chapter 50 | 233 | ||
| Immunosuppressant drugs | 233 | ||
| Chapter 51 | 233 | ||
| Immunizing drugs and pandemic preparedness | 233 | ||
| Chapter 52 | 234 | ||
| Antineoplastic drugs part 1: Cancer overview and cell cycle–specific drugs | 234 | ||
| Critical thinking crossword | 234 | ||
| Chapter 53 | 234 | ||
| Antineoplastic drugs part 2: Cell cycle–nonspecific and miscellaneous drugs | 234 | ||
| Chapter 54 | 235 | ||
| Biological response–modifying drugs and antirheumatic drugs | 235 | ||
| Chapter 55 | 236 | ||
| Anemia drugs | 236 | ||
| Chapter 56 | 236 | ||
| Dermatological drugs | 236 | ||
| Chapter 57 | 237 | ||
| Ophthalmic drugs | 237 | ||
| Chapter 58 | 237 | ||
| Otic drugs | 237 | ||
| Overview of dosage calculations | 238 | ||
| Introduction | 238 | ||
| Section I | 238 | ||
| Section II | 238 | ||
| Section III | 239 | ||
| Section IV | 239 | ||
| Section V | 240 | ||
| Practice quiz | 240 | ||
| Pharmaceutical abbreviations | ES3 |